santa cruz biotechnology, inc.
SCBT Logo
Product Search
Willkommen!    0 Produkt(e) im Warenkorb.     Bestellen
Home »  Supportprodukte » Biologically Active Peptides: Substrates and Inhibitors
  Biologically Active Peptides: Substrates and Inhibitors
PRODUKT CATALOG # DESCRIPTION AMOUNT
sc-3063
Synthetic activator of adenylate cyclases more potent at stimulating adenylate cyclases sequence: HSDGIFTDSYRYRLQMAVKKYLAAVLGKRYLQRVKDK (>97% pure by HPLC)
synthetic activator of adenylate cyclases, 0.5 mg/0.1 ml
sc-3025
Substrate
n/a
sc-3089
cyclin degradation. Inhibits Calpain and cathepsin L and B
synthetic inhibitor of calpain, 0.5 mg/0.1 ml
sc-3062
Inhibitor
sc-3030
Inhibitor
sc-3117
synthetic inhibitor for Autocamtide-2, 0.5 mg/0.1 ml
sc-3037
synthetic inhibitor of CaM Kinase II, 0.5 mg/0.1 ml
sc-3039
synthetic inhibitor of CaM Kinase II, 0.5 mg/0.1 ml
sc-3119
substrate
synthetic substrate for CaM Kinase II, 0.5 mg/0.1 ml
sc-3029
substrate
synthetic substrate for CaM Kinase II, 0.5 mg/0.1 ml
sc-3118
synthetic substrate for CaM Kinase II, 0.5 mg/0.1 ml
sc-3028
Substrate
synthetic substrate for CaM Kinase IV, 0.5 mg/0.1 ml
sc-3120
Substrate
synthetic substrate for casein kinase I, 0.5 mg/0.1 ml
sc-3046
Substrate
synthetic substrate for casein kinase II, 0.5 mg/0.1 ml
sc-3121
Substrate
synthetic substrate for casein kinase II, 0.5 mg/0.1 ml
sc-3068
Ac-VAD-cho, Inhibits caspase-1,3,4,7
Ac-VAD-cho, Inhibits caspase-1,3,4,7, 0.5 mg/0.1 ml
sc-3070
Ac-YVAD-cho, Inhibits caspase-1 and 4
Ac-YVAD-cho, Inhibits caspase-1 and 4, 0.5 mg/0.1 ml
sc-3058
Substrate
synthetic substrate for caspase-1 and caspase-4, 0.5 mg/0.1 ml
sc-3073
Ac-DEVD-cho, Inhibits caspases-3,6,7,8,10
Ac-DEVD-cho, Inhibits caspases-3,6,7,8,10, 0.5 mg/0.1 ml
sc-3076
Ac-LEVD-cho, Inhibits caspase-4
Ac-LEVD-cho, Inhibits caspase-4, 0.5 mg/0.1 ml
sc-3078
z-WHED-fmk, Inhibits caspase-5
z-WEHD-fmk, Inhibits caspase-5, 0.5 mg/0.1 ml
sc-3082
Ac-IEFD-cho, Inhibits caspase-8 and granzyme B
Ac-IEFD-cho, Inhibits caspase-8 and granzyme B, 0.5 mg/0.1 ml
sc-3131
Z-FA-FMK
Z-FA-FMK, 0.5 mg
sc-3133
Z-RR-AMC
Z-RR-AMC, 0.5 mg
sc-3134
Suc-AAPF-pNA, excellent substrate for the quantitative determination of cathepsin G activity
Suc-AAPF-pNA, excellent substrate for the quantitative determination of cathepsin G activity, 0.5 mg
sc-3130
Z-FG-NHO-Bz, selectively inhibits cathepsins B, L, S and papain
Z-FG-NHO-Bz, selectively inhibits cathepsins B, L, S and papain, 0.5 mg
sc-3132
Z-FY-CHO, a potent and selective inhibitor of cathepsin L
Z-FY-CHO, a potent and selective inhibitor of cathepsin L, 0.5 mg
sc-3136
Z-FR-AMC, excellent substrate for cathepsin L. Also useful as a substrate for cathepsin B
Z-FR-AMC, excellent substrate for cathepsin L. Also useful as a substrate for cathepsin B, 0.5 mg
sc-3065
Substrate
sc-3056
Substrate
sc-3066
Substrate
sc-3049
Substrate
n/a
sc-362738
1 mg
sc-3128
Substrate
fluorogenic substrate for measuring the peptidase activity of the 20S proteasome, 0.5 mg/0.1 ml
sc-3129
Substrate
fluorogenic substrate for measuring the peptidase activity of the 20S proteasome, 0.5 mg/0.1 ml
sc-3087
Ac-IETD-cho, Inhibits caspase-8 and granzyme B
Ac-IETD-cho, Inhibits caspase-8 and granzyme B, 0.5 mg/0.1 ml
sc-3114
Substrate
synthetic substrate for GSK-3β, 0.5 mg/0.1 ml
sc-3115
Substrate
synthetic substrate for GSK-3β, 0.5 mg/0.1 ml
sc-3048
sequence: TRDIYETDYYRK (>97% pure by HPLC)
sc-3560
A potent, selective inhibitor of Ca2+calmodulin kinase II.
1 mg
sc-3141
Reversible inhibitor of serine and cysteine proteases such as calpain, plasmin, trypsin, papain, and cathepsin B, no inhibition found with pepsin, cathepsins A and D, thrombin, or α-chymotrypsin; recommended starting concentration 0.5 µg/ml.
Reversible inhibitor of trypsin-like proteases and cysteine proteases., 0.5 mg/0.1 ml
sc-3013
peptide substrate for ERK 1 and ERK 2 MAP kinases, 0.5 mg/0.1 ml
peptide substrate for ERK 1 and ERK 2 MAP kinases, 0.5 mg/0.1 ml
sc-3011
Substrate
peptide substrate for ERK 1 and ERK 2 MAP kinases, 0.5 mg/0.1 ml
sc-3091
Inhibitor
n/a
sc-3014
0.5 mg/0.1 ml
tyrosine phosphorylation ª 170 µM
sc-3043
synthetic substrate for MLCK, 0.5 mg/0.1 ml
sc-3045
synthetic inhibitor for MYLK2, 0.5 mg/0.1 ml
sc-3044
synthetic substrate for MYLK2, 0.5 mg/0.1 ml
sc-3138
synthetic ligand
synthetic ligand for NK-1R2, 0.5 mg/0.1 ml
sc-3139
synthetic ligand
synthetic ligand for NK-1R3, 0.5 mg/0.1 ml
sc-3140
Synthetic potassium channel blocker. Potent vasocon. Reversibly inhibits Ca2+-activated K+ channels in vascular smooth muscle cells.
Synthetic potassium channel blocker. Potent vasocon, 0.5 mg/0.1 ml
sc-3061
synthetic control
synthetic control for NFκB inhibitor, 0.5 mg/0.1 ml
sc-3060
Inhibitor
synthetic inhibitor for NFκB, 0.5 mg/0.1 ml
sc-3009
Substrate
231-239 (h)
sc-3036
sequence: KKHTDDGYMPMSPGVA (>97% pure by HPLC)
sc-3010
Inhibitor
N-terminus (h)
sc-3034
Synthetic activator of PLA2 derived from PLAP.
Synthetic activator of PLA2, 0.5 mg/0.1 ml
sc-3055
Inhibitor
synthetic inhibitor for PP2B, 0.5 mg/0.1 ml
sc-3053
Substrate
synthetic substrate for PP2B, 0.5 mg/0.1 ml
sc-3054
Substrate
synthetic substrate for PP2B, 0.5 mg/0.1 ml
sc-3127
Inhibitor
synthetic peptide inhibitor for proteasomes, 0.5 mg/0.1 ml
sc-3142
microinjection
internal (h)
sc-3126
Substrate
n/a
sc-3123
sequence: TSTEPQYQPGENL (>97% pure by HPLC)
sc-3122
Inhibitor
n/a
sc-3124
sequence: VPPPVPPRRR (>97% pure by HPLC)
sc-3137
synthetic ligand for NK-1R, 0.5 mg/0.1 ml
sc-3015
Substrate
n/a
sc-362800
1 mg
sc-3090
Substrate
n/a